Sign inJoin waitlistJoin the waitlist

AK

Amy Kimball

Hematology & Oncology

Credentials: ·

History

Hematology and Medical Oncology
2010–2013
Internal Medicine
2007–2010
Medical School
2003–2007

Research

Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and Subgroups
Clinical Lymphoma · 2019 · 57 citations
Weekly carfilzomib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A phase 1b study
American Journal of Hematology · 2019 · 13 citations
A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma
American Journal of Hematology · 2021 · 3 citations

David Siegel
2 papers
JB
Jesus Berdeja
2 papers
MA
Melissa Alsina
2 papers
NR
Noopur Raje
2 papers
Ola Landgren
2 papers
Ruben Niesvizky
2 papers
Tibor Kovacsovics
2 papers
David Vesole
1 paper
Michael Kallen
1 paper
Noa Biran
1 paper
RC
Robert Cornell
1 paper
Robert Orlowski
1 paper